Simplify Logo

Full-Time

Bill of Materials Specialist

Confirmed live in the last 24 hours

Natera

Natera

1,001-5,000 employees

Biotechnology firm specializing in genetic testing

Hardware
Biotechnology
Healthcare

Senior, Expert

Austin, TX, USA

Category
Inventory Management
Production Planning & Scheduling
Procurement & Sourcing
Supply Chain Management
Operations & Logistics
Required Skills
Management
Requirements
  • Bachelor's Supply Chain Management, related field or minimum 5 years’ experience maintaining BOM’s within bio-tech field.
  • Proven experience as a BOM Specialist or similar role in a manufacturing environment.
  • Strong understanding of bill of materials (BOM) structure, components, and relationships.
  • Proficiency in BOM management tools/software (e.g., ERP systems, PLM software).
  • Ability to prioritize tasks, meet deadlines, and adapt to changing priorities in a fast-paced environment.
  • Knowledge of industry standards and regulations related to BOM management (e.g., ISO 9001 is a plus.)
Responsibilities
  • Establish and streamline efficient processes for maintaining accurate, complete, and consistent bill of materials (BOM) across all products in ERP management software.
  • Review specifications, and other documentation to accurately capture BOM information.
  • Collaborate with R&D, PDO, Procurement, and Manufacturing teams to identify and resolve UOM discrepancies or inconsistencies in BOMs.
  • Implement and maintain BOM revision control processes to manage changes and updates effectively.
  • Monitor and analyze BOM data for cost optimization, quality improvement, and inventory management.
  • Support new product introduction (NPI).
  • Coordinate with suppliers to ensure BOM purchasing UOM accuracy.
  • Provide training and guidance to cross-functional teams on BOM best practices and processes.
  • Coordinate planning activities with cross-functional departments to ensure project milestones are achieved on-time.
  • Implement new or improved supply chain processes to improve efficiency or performance.
  • Maintain item master data to support planner code and production order policy data.

Natera focuses on genetic testing and diagnostics, providing advanced solutions for cancer patients, transplant patients, and individuals assessing hereditary health risks. Their main technology, cell-free DNA (cfDNA) testing, analyzes DNA fragments in the blood to detect minimal traces of cancer and assess organ health. Natera stands out by offering specialized tests like the Signatera ctDNA test and Panorama NIPT, along with genetic counseling services. The company's goal is to improve patient care through accurate genetic insights and early detection of health issues.

Company Stage

IPO

Total Funding

$1.2B

Headquarters

Austin, Texas

Founded

2004

Growth & Insights
Headcount

6 month growth

8%

1 year growth

20%

2 year growth

52%
Simplify Jobs

Simplify's Take

What believers are saying

  • Natera's continuous innovation, such as the launch of the Prospera Heart test with DQS, demonstrates its commitment to improving patient outcomes and maintaining market leadership.
  • The company's diverse product offerings across oncology, transplant health, and women's health provide multiple revenue streams and reduce dependency on a single market.
  • Significant investments from entities like Massachusetts Financial Services Co. MA indicate strong financial backing and confidence in Natera's growth potential.

What critics are saying

  • Allegations of deceptive sales and billing practices could damage Natera's reputation and lead to legal and financial repercussions.
  • The highly competitive nature of the genetic testing market requires constant innovation and differentiation to maintain market share.

What makes Natera unique

  • Natera's focus on cell-free DNA (cfDNA) technology for a wide range of applications, from oncology to prenatal screening, sets it apart from competitors who may specialize in only one area.
  • The introduction of unique features like the Donor Quantity Score (DQS) for transplant rejection detection enhances the accuracy and reliability of their tests, distinguishing them from other genetic testing companies.
  • Natera's extensive portfolio of over 200 peer-reviewed publications underscores its commitment to scientific validation and credibility, which is a significant competitive advantage.

Benefits

Flexible medical plans

Investment options

Time off

Workplace perks